Ramsay Generale dente (XPAR:GDS) Cash And Cash Equivalents : €189 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Ramsay Generale dente Cash And Cash Equivalents?

Ramsay Generale dente's quarterly cash and cash equivalents increased from Dec. 2022 (€220.90 Mil) to Jun. 2023 (€352.20 Mil) but then stayed the same from Jun. 2023 (€352.20 Mil) to Dec. 2023 (€188.60 Mil).

Ramsay Generale dente's annual cash and cash equivalents declined from Jun. 2021 (€608.40 Mil) to Jun. 2022 (€132.50 Mil) but then increased from Jun. 2022 (€132.50 Mil) to Jun. 2023 (€352.20 Mil).

Ramsay Generale dente Cash And Cash Equivalents Historical Data

The historical data trend for Ramsay Generale dente's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ramsay Generale dente Cash And Cash Equivalents Chart

Ramsay Generale dente Annual Data

Trend

Dec13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash And Cash Equivalents

Get a 7-Day Free Trial

368.50

538.20

608.40

132.50

352.20

Ramsay Generale dente Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															408.10	132.50	220.90	352.20	188.60

Ramsay Generale dente Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Ramsay Generale dente (XPAR:GDS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Ramsay Generale dente Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Ramsay Generale dente's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Ramsay Generale dente (XPAR:GDS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ramsay Generale de Sante SA (XPAR:GDS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

GD6:Germany

Address

39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017

Website

https://www.ramsaygds.fr

Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.